https://www.selleckchem.com/products/VX-702.html
Infant acute myeloid leukemia (AML) is a rare subgroup of AML of children less then 2 years of age. It is as frequent as infant acute lymphoblastic leukemia (ALL) but not clearly distinguished by study groups. However, infant AML demonstrates peculiar clinical and biological characteristics, and its prognosis differs from AML in older children. Acute megakaryoblastic leukemia (AMKL) is very frequent in this age group and has raised growing interest. Thus, AMKL is a dominant topic in this review. Recent genomic sequencing has contributed
إعجاب
علق
شارك
